The flipside of Notch

Demetrios Kalaitzidis () and Scott A. Armstrong ()
Additional contact information
Demetrios Kalaitzidis: Demetrios Kalaitzidis and Scott A. Armstrong are at Children's Hospital Boston, and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Scott A. Armstrong: Demetrios Kalaitzidis and Scott A. Armstrong are at Children's Hospital Boston, and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Nature, 2011, vol. 473, issue 7346, 159-160

Abstract: Mutations that lead to increased activity of the Notch signalling pathway are well defined in human cancer. New work implicates decreased activity of this pathway in a type of blood cancer. See Letter p.230

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/473159a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:473:y:2011:i:7346:d:10.1038_473159a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/473159a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().